DXCM DEXCOM INC Legal Disputes 8-K Filing 2025 - FDA Warning Letter On March 4, 2025, Dexcom received a warning letter from the FDA regarding deficiencies in its manufacturing processes, but it does not expect this to impact its production or revenue guidance for fiscal year 2025.Get access to all SEC 8-K filings of the DEXCOM INC